Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis.
about
Ramifications of four concurrent thrombophilic mutations and one hypofibrinolytic mutationPulmonary embolism as a complication of an electrophysiological study: a case report.Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacementIncreased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study.Clear cell carcinoma of the ovary associated with increased risk of venous thrombosis.Sudden Death by Pulmonary Thromboembolism due to a Large Uterine Leiomyoma with a Parasitic Vein to the Mesentery.Interdisciplinary management of deep vein thrombosis during rehabilitation of acute rupture of the anterior cruciate ligament: a case report.Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancerCancer and venous thromboembolism: scope of the problem.Pulmonary thromboembolism in AIDS patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: a case report and pathophysiology review.Pulmonary embolism related to amisulpride treatment: a case reportTransitions of care in anticoagulated patients.Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms.AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.Elevated heparin-induced antibodies are more common in diabetic patients with vascular disease.Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study.Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty.Management of venous thromboembolism for older adults in long-term care facilities.Anticoagulant use in real time.Medico-Legal Aspects of Pulmonary Thromboembolism.Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.Use of a modified dosing weight for heparin therapy in a morbidly obese patient.The Role of Inflammation in Venous Thromboembolism.Recent progress and market analysis of anticoagulant drugs.
P2860
Q28171246-E9EC4453-4AA3-414F-8B42-A97198731B8CQ33167048-F78A5242-71A9-4C18-B928-042175E25BE3Q33384243-AA2615E3-F746-4384-B375-1AFAAD9DE08EQ33773146-C5553EF0-30D1-488B-AE4D-B707B1749439Q34632105-93E8C287-08B9-4495-88B7-150822ED585BQ34814914-B04D60BB-BC1B-4D91-A1FA-1951CE68BFEDQ35064768-11045122-FFF1-4A27-A8B5-B752543FD0EAQ36251473-685234F9-867F-4F7B-B15A-AE6787E8050AQ36265569-9B082C35-5723-440E-8015-9BD6AC3B65B5Q36478255-4D7FBB8F-837B-4C8F-A85C-539298875A91Q36692244-46D42F63-CDEA-47DA-BD5D-3E21F6F94CBEQ36957947-6D52CFBE-FACC-4D59-91B4-242EC811E2DAQ36976957-9ECB5D03-AB27-4EE0-A077-13AC895DE116Q37496271-C176C309-C9B7-4FF0-83B6-F005E12F5AE2Q37615123-E294E75D-F0CE-437A-9E2F-29E3FB8F6701Q37693298-4B298E98-4690-48D1-879A-3F2B812FE256Q37903077-B78A2D08-FEA5-4F1A-AC80-E3F003CA58A2Q38016583-C28A9EAE-C2A1-4913-9DB6-7CAABCD8ACC6Q38062284-1A02D0FC-702A-4CC8-9880-764473BB1478Q38952571-E47C326F-5A7A-4D16-B3F0-461AF835705DQ46964311-B14C5ECB-F805-4391-9D2B-B3642575D013Q47390135-FEA007D5-074D-45BB-86E3-A2EEA7DFA07CQ54956023-47A606C3-3897-4A18-8A1D-4EFEC06C6D56Q55072550-57848FD8-B309-4C10-ACD7-7816EA9FB5B1
P2860
Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@ast
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@en
type
label
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@ast
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@en
prefLabel
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@ast
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@en
P356
P1433
P1476
Principle mechanisms underlyin ...... hophysiology and pathogenesis.
@en
P2093
Angelika Reissig
Claus Kroegel
P356
10.1159/000068427
P577
2003-01-01T00:00:00Z